Nutritional Supplementation in Head and Neck Cancers
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorAHS Cancer Control Alberta
About this trial
The purpose of this study is to determine whether multimodal nutrition therapy (primary nutrition intervention + adjuvant nutrition therapy) will support patients to optimize their total caloric intake during cancer treatment by measuring the difference in mean cumulative energy intake between the intervention and control group over the duration of cancer treatment.
Eligibility criteria
Qualifiers
Patients must have the ability to read, understand, and sign an informed consent and must be willing to comply with study treatment and follow-up.
Male or female
≥18 years of age
Histopathologically confirmed primary squamous cell carcinoma of the oral cavity and oropharynx, larynx or hypopharynx, who have agreed to receive radical intent radiotherapy as primary treatment or adjuvant treatment post-surgery, with or without platinum chemotherapy
Disqualifiers
Fed by nasogastric tube, gastrostomy or total parenteral nutrition
Cancer of the nasopharynx, thyroid or salivary gland
Life expectancy <6 months.
A known hypersensitivity / allergy to the investigational product or to any ingredient in their formulations (e.g. Milk/Lactose, Fish).
Trial design
Treatments tested in this trial
- Resource® Support Plus
Treatment groups
81 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov